Trial and failure - PubMed (original) (raw)

Editorial

. 2007 Mar 1;446(7131):1.

doi: 10.1038/446001a.

• PMID: 17330004
• DOI: 10.1038/446001a

Editorial

Trial and failure

No authors listed. Nature. 2007.

No abstract available

PubMed Disclaimer

Similar articles

• Scientists rethink approach to HIV gels.
  Check E. Check E. Nature. 2007 Mar 1;446(7131):12. doi: 10.1038/446012a. Nature. 2007. PMID: 17330015 No abstract available.
• After microbicide failures, hope that antiviral approach will gel.
  Padma TV. Padma TV. Nat Med. 2008 Apr;14(4):354. doi: 10.1038/nm0408-354a. Nat Med. 2008. PMID: 18391925 No abstract available.
• Drug firms donate compounds for anti-HIV gel.
  Towie N. Towie N. Nature. 2005 Nov 3;438(7064):6-7. doi: 10.1038/438006b. Nature. 2005. PMID: 16267513 No abstract available.
• The development of vaginal microbicides for the prevention of HIV transmission.
  Weber J, Desai K, Darbyshire J; Microbicides Development Programme. Weber J, et al. PLoS Med. 2005 May;2(5):e142. doi: 10.1371/journal.pmed.0020142. Epub 2005 May 31. PLoS Med. 2005. PMID: 15916473 Free PMC article. Review.
• Microbicides and barrier methods in HIV prevention.
  Van Damme L, Rosenberg ZF. Van Damme L, et al. AIDS. 1999;13 Suppl A:S85-92. AIDS. 1999. PMID: 10885766 Review. No abstract available.

Cited by

• Does Male Circumcision Reduce Women's Risk of Sexually Transmitted Infections, Cervical Cancer, and Associated Conditions?
  Morris BJ, Hankins CA, Banerjee J, Lumbers ER, Mindel A, Klausner JD, Krieger JN. Morris BJ, et al. Front Public Health. 2019 Jan 31;7:4. doi: 10.3389/fpubh.2019.00004. eCollection 2019. Front Public Health. 2019. PMID: 30766863 Free PMC article.
• Pre-exposure prophylaxis of HIV: A right way to go or a long way to go?
  Yu W, Wang L, Han N, Zhang X, Mahapatra T, Mahapatra S, Babu GR, Tang W, Detels R, Zhao J. Yu W, et al. Artif Cells Nanomed Biotechnol. 2016;44(1):201-8. doi: 10.3109/21691401.2014.934458. Epub 2014 Jul 31. Artif Cells Nanomed Biotechnol. 2016. PMID: 25078629 Free PMC article. Review.
• Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection.
  Katlama C, Murphy R. Katlama C, et al. Ther Clin Risk Manag. 2009 Apr;5(2):331-40. doi: 10.2147/tcrm.s3137. Epub 2009 May 4. Ther Clin Risk Manag. 2009. PMID: 19536321 Free PMC article.
• In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?
  Lavery JV, Singer PA, Ridzon R, Singh JA, Slutsky AS, Anisko JJ, Buchanan D. Lavery JV, et al. PLoS Med. 2009 Jun 9;6(6):e1000071. doi: 10.1371/journal.pmed.1000071. Epub 2009 Jun 9. PLoS Med. 2009. PMID: 19513106 Free PMC article.
• The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study.
  Vissers DC, Voeten HA, Nagelkerke NJ, Habbema JD, de Vlas SJ. Vissers DC, et al. PLoS One. 2008 May 7;3(5):e2077. doi: 10.1371/journal.pone.0002077. PLoS One. 2008. PMID: 18461185 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Medical

  • MedlinePlus Health Information